FULCRUM THERAPEUTICS

Fulcrum Therapeutics Provides Business Update and 2023 Outlook

04 1 2023 06:02:00 提供 Nasdaq GlobeNewswire

Fulcrum Therapeutics Announces CEO Transition

04 1 2023 06:01:00 提供 Nasdaq GlobeNewswire

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 12 2022 16:20:59 提供 Nasdaq GlobeNewswire

Fulcrum Therapeutics to Participate at Upcoming 2022 BofA Securities Biotech SMID Cap Conference

01 12 2022 15:01:00 提供 Nasdaq GlobeNewswire

Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11 11 2022 17:33:20 提供 Nasdaq GlobeNewswire

Fulcrum Therapeutics Announces Recent Business Highlights and Third Quarter 2022 Financial Results

08 11 2022 06:17:58 提供 Nasdaq GlobeNewswire

Fulcrum Therapeutics Appoints Chief Medical Officer and Chief Scientific Officer

07 11 2022 16:00:00 提供 Nasdaq GlobeNewswire

Fulcrum Therapeutics® to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Tuesday, November 8, 2022 at 8:00 a.m. ET

02 11 2022 06:05:00 提供 Nasdaq GlobeNewswire

Fulcrum Therapeutics® to Participate at Upcoming November Investor Conferences

01 11 2022 16:29:02 提供 Nasdaq GlobeNewswire

Fulcrum Therapeutics to Present New Data from the Open Label Extension of Phase 2 ReDUX4 Study at the World Muscle Society (WMS) Congress in Halifax, Canada

12 10 2022 06:30:00 提供 Nasdaq GlobeNewswire

Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

07 10 2022 16:00:00 提供 Nasdaq GlobeNewswire

Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

09 9 2022 16:00:00 提供 Nasdaq GlobeNewswire

Fulcrum Therapeutics to Participate at Upcoming September Investor Conferences

06 9 2022 15:01:00 提供 Nasdaq GlobeNewswire

Fulcrum Therapeutics® to Participate at the Upcoming Stifel 2022 Biotech Summer Summit

16 8 2022 06:05:00 提供 Nasdaq GlobeNewswire

Fulcrum Therapeutics Announces Pricing of Public Offering of Common Stock

15 8 2022 20:28:02 提供 Nasdaq GlobeNewswire

Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock

15 8 2022 15:08:15 提供 Nasdaq GlobeNewswire

Fulcrum Therapeutics Announces Second Quarter 2022 Financial Results and Business Update

11 8 2022 06:00:02 提供 Nasdaq GlobeNewswire

Fulcrum Therapeutics® to Host Second Quarter 2022 Financial Results Conference Call and Webcast on Thursday, August 11, 2022 at 8:00 a.m. ET

04 8 2022 07:07:44 提供 Nasdaq GlobeNewswire

Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 8 2022 07:00:02 提供 Nasdaq GlobeNewswire

Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

15 7 2022 07:00:00 提供 Nasdaq GlobeNewswire